We appreciate the letter writer's interest in our manuscript and agree that their two referenced articles add to the growing literature on both the efficacy and cost-effectiveness of PGT-A. The goals and theoretical models implemented in each paper are distinct, and it is therefore challenging to draw direct comparisons amongst their conclusions. In our study, we developed a novel model to determine the expected out-ofpocket costs of IVF with PGT-A based on individual age and AMH. However, we strongly disagree that PGT-A should be confined to study protocols. On the contrary, we feel that PGT should be available and offered, and that counseling patients regarding this technology should include a discussion of estimated costs. We believe that, following a discussion of the benefits, limitations, and costs of PGT-A, well-informed patients should be able to decide what is right for them.
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